These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 16954257

  • 1. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.
    Spanu T, Sanguinetti M, Tumbarello M, D'Inzeo T, Fiori B, Posteraro B, Santangelo R, Cauda R, Fadda G.
    J Clin Microbiol; 2006 Sep; 44(9):3257-62. PubMed ID: 16954257
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases.
    Robin F, Delmas J, Schweitzer C, Bonnet R.
    Clin Microbiol Infect; 2008 Feb; 14(2):148-54. PubMed ID: 18076663
    [Abstract] [Full Text] [Related]

  • 3. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H.
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L, Brossier F, Sougakoff W, Jarlier V.
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D.
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [Abstract] [Full Text] [Related]

  • 8. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME, Karageorgopoulos DE.
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [Abstract] [Full Text] [Related]

  • 9. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Mendes RE, Rhomberg PR, Bell JM, Turnidge JD, Sader HS.
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital.
    Jamal W, Rotimi VO, Khodakhast F, Saleem R, Pazhoor A, Al Hashim G.
    Med Princ Pract; 2005 Apr; 14(5):325-31. PubMed ID: 16103698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y, Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN, Kohno S, SENTRY Asia-Pacific Participants.
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D.
    Med Princ Pract; 2008 Aug; 17(1):32-6. PubMed ID: 18059098
    [Abstract] [Full Text] [Related]

  • 14. Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates.
    Tuchiluş C, Poiată A, Bosnea D, Bădicuţ I, Buiuc D.
    Roum Arch Microbiol Immunol; 2002 Aug; 61(4):285-91. PubMed ID: 15055262
    [Abstract] [Full Text] [Related]

  • 15. Extended spectrum beta lactamase--mediated resistance among isolates of family Enterobacteriaceae.
    Deep, Arora U.
    Indian J Pathol Microbiol; 2007 Apr; 50(2):458-61. PubMed ID: 17883109
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Behera B, Mathur P, Das A, Kapil A.
    Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS.
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Singh RM, Singh HL.
    J Infect Dev Ctries; 2014 Apr 15; 8(4):408-15. PubMed ID: 24727505
    [Abstract] [Full Text] [Related]

  • 20. Plasmid profile of ESBL producing Gram-negative bacteria and correlation with susceptibility to beta-lactam drugs.
    Sharma J, Ray P, Sharma M.
    Indian J Pathol Microbiol; 2010 Apr 15; 53(1):83-6. PubMed ID: 20090229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.